68135-058 : Palynziq 2.5 mg/.5ml Subcutaneous Injection, Solution

Labeler: Biomarin Pharmaceutical Inc.
Product Type: Human Prescription Drug
Drug Name:  Palynziq
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA761079
Rev. Date: 

NDC Package Codes:

  • 68135-058-90: 1 SYRINGE IN 1 CARTON (68135‑058‑90) > .5 ML IN 1 SYRINGE (68135‑058‑89)

Active Ingredients:

  • Pegvaliase

Dosage Strength:

  • 2.5 mg/.5mL

Pharmaceutical Classes:

  • Phenylalanine Metabolizing Enzyme [EPC]
  • Phenylalanine Ammonia-Lyase [CS]

Related Products:

Based on records with the same trade name.
  • 68135-673 Palynziq 20 mg/ml Subcutaneous Injection, Solution by Biomarin Pharmaceutical Inc.
  • 68135-756 Palynziq 10 mg/.5ml Subcutaneous Injection, Solution by Biomarin Pharmaceutical Inc.


Scan the QR code below to easily reference this data in the future:

NDC 68135-058 QR Code

< Prev: 68135-020Next: 68135-100 >

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 June 2018.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA